RA – Diagnosis, Manifestations, & Outcomes Poster IV: Lifespan of a Disease
Monday, November 9, 2020
9:00 AM – 11:00 AM ET
Poster session.
Presentations:
9:00 AM – 11:00 AM ET
Exploring Novel Tenosynovitis and Combined Inflammation Imaging Outcomes: Results from a Randomized Controlled Trial in Early Rheumatoid Arthritis Philip Conaghan, MD, PhD – University of Leeds
9:00 AM – 11:00 AM ET
Disease Activity Trajectories for Early and Established Rheumatoid Arthritis: Real World Results from a Rheumatoid Arthritis Cohort Claire Bombardier, MD, FRCPC – University of Toronto - Toronto
9:00 AM – 11:00 AM ET
Longitudinal Patterns of Remission in Real-World Early Rheumatoid Arthritis Patients: Results from the Canadian Early Arthritis Cohort (CATCH) Orit Schieir, PhD – Canadian Early Arthritis Cohort Study
9:00 AM – 11:00 AM ET
Predictors of Unacceptable Pain and Unacceptable Pain with Low Inflammation in Early Rheumatoid Arthritis Anna Eberhard, MD – Rheumatology, Department of Clinical Sciences, Malmö, Lund University
9:00 AM – 11:00 AM ET
Impact of Treatments on Favorable Outcome over the First 10 Years of Disease in Early Rheumatoid Arthritis: Results from a WCE Model in the ESPOIR Cohort Joanna Kedra, MD, MSc – Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, UMR S1136, Paris, France
9:00 AM – 11:00 AM ET
Impact of Treatments on Radiographic Progression over the First 10 Years of Disease in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort Joanna Kedra, MD, MSc – Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique, UMR S1136, Paris, France
9:00 AM – 11:00 AM ET
Prevalence and Trajectory of Erosions, Synovitis, and Bone Marrow Edema in Feet of Patients with Early Rheumatoid Arthritis Zechen Ma – McMaster University
9:00 AM – 11:00 AM ET
Factors Associated with an Increased Risk of Imminent Rheumatoid Arthritis in ACPA+ Individuals Kevin D. Deane, MD, PhD – University of Colorado Denver
9:00 AM – 11:00 AM ET
Increasing Autoantibody Positivity During Pre-RA Is Associated with the Imminent Development of Classifiable RA Kevin D. Deane, MD, PhD – University of Colorado Denver
9:00 AM – 11:00 AM ET
Predicting Rheumatoid Arthritis Using the Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire Laurette van Boheemen – Reade
9:00 AM – 11:00 AM ET
RA Flare Prediction via Machine Learning and Algorithm Based on SSDM Big Data Yan Zhao, MD – Peking Union Medical College hospital
9:00 AM – 11:00 AM ET
A Feasible and Efficient Approach to Implementing Rheumatoid Arthritis Disease Activity Measure in a Busy Rheumatology Clinic: A Quality Improvement Project Ali H. Ali, MD – UCSF Fresno
9:00 AM – 11:00 AM ET
An Investigation of the Relationship Between Patient Reported Outcomes and Biomarkers in a Community Rheumatology Practice Elston He – Synovium, Inc.
9:00 AM – 11:00 AM ET
Assessment of the Components of RAPID3 Patient Reported Outcomes in an Community Rheumatology Practice Elston He – Synovium, Inc.
9:00 AM – 11:00 AM ET
Patterns of Fatigue in Early RA over 10 Years: Results from the ESPOIR Cohort Samantha Rodriguez Muguruza, MD – Joan XXIII Hospital
9:00 AM – 11:00 AM ET
Patient-Reported Outcomes of Upadacitinib versus Abatacept in Patients with Rheumatoid Arthritis and an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: 12-Week Results of a Phase 3 Study Martin Bergman, MD – Drexel University College of Medicine
9:00 AM – 11:00 AM ET
Associations Between Patient Reported Outcomes and Impairments of Work and Activity in Patients with Rheumatoid Arthritis Who Achieved Clinical Remission; Retrospective Analysis Using the IORRA Database Ryoko Sakai, PhD, MSc, MPH – Tokyo Women's Medical University
9:00 AM – 11:00 AM ET
Comparison of MBDA Score, Patient Global Assessment and Evaluator Global Assessment for Predicting Risk of Radiographic Progression Leonard H. Calabrese, DO – Cleveland Clinic
9:00 AM – 11:00 AM ET
Development of a Disease Activity Index for Rheumatoid Arthritis Patients Using the HandScan Maxime Verhoeven – UMC Utrecht
9:00 AM – 11:00 AM ET
Machine Learning Coupled with Patient Reported Outcome Data to Classify & Predict RA Disease Activity Jeffrey R R. Curtis, MD, MS, MPH – University of Alabama at Birmingham
9:00 AM – 11:00 AM ET
Patients with Rheumatoid Arthritis and Comorbid Depression Have High Levels of RAPID3 (Routine Assessment of Patient Index Data) and FAST3 (Fibromyalgia Assessment Screening Index) on a Multidimensional Health Assessment Questionnaire (MDHAQ) Rosa Morlà, PhD – Hospital Universitari Clínic de Barcelona
9:00 AM – 11:00 AM ET
The Challenge of Assessing Wellbeing from the Patients` Perspective in Early Rheumatoid Arthritis Diederik De Cock, PhD – KU Leuven
9:00 AM – 11:00 AM ET
Effect of Aerobic Land-based Exercise Intervention on Fatigue in Rheumatoid Arthritis: A Systematic Review and Meta-analysis Samar Aboulenain, MD – University of Miami Miller School
9:00 AM – 11:00 AM ET
Health Assessment Questionnaire Predicts All-Cause Mortality at One Year in Patients with Early Rheumatoid Arthritis Safoora Fatima, MD – University of Western Ontario
9:00 AM – 11:00 AM ET
What Influences Fatigue Improvement in Rheumatoid Arthritis? A Prospective Cohort Study Samar Aboulenain, MD – University of Miami Miller School
9:00 AM – 11:00 AM ET
Promote Treat-to-Target for RA via Empowering Patients: A Cohort Study from China by Smart System of Disease Management (SSDM) JING YANG, MD – Rheumatology
9:00 AM – 11:00 AM ET
Patients with Early Rheumatoid Arthritis Considered to Have a Favourable Risk Profile and Treated According to a Step-up Strategy Have an Increased Risk of Chronic Analgesic Consumption Sofia Pazmino, MD – KU Leuven
9:00 AM – 11:00 AM ET
Determinants of Influenza Vaccine Hesitancy in Rheumatoid Arthritis According to the WHO-SAGE Matrix Mariana Useche, MD – McGill University
9:00 AM – 11:00 AM ET
Does Preventive Care Matter? (in RA) Morgan Greenwald, BA – Desert Medical Advances
9:00 AM – 11:00 AM ET
Patients’ and Rheumatologists’ Perceptions on Preventive Intervention in Rheumatoid Arthritis and Axial Spondyloarthritis Laurette van Boheemen – Reade
9:00 AM – 11:00 AM ET
Perioperative Steroids in Rheumatoid Arthritis Patients Having Total Joint Replacements: Help or Harm? Susan M. Goodman, MD – Hospital for Special Surgery
9:00 AM – 11:00 AM ET
The STAtins to Prevent Rheumatoid Arthritis (STAPRA) Trial: Clinical Results and Subsequent Qualitative Study, a Mixed Method Evaluation Laurette van Boheemen – Reade
9:00 AM – 11:00 AM ET
A Novel Method for Predicting 1-Year Retention of Abatacept Using Machine Learning Techniques Rieke Alten, MD, PhD, Professor of Medicine – SCHLOSSPARK KLINIK, University Medicine Berlin
9:00 AM – 11:00 AM ET
Association of Obesity with Treatment Response to Methotrexate or Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Dilli R. Poudel, MD – University of Pennsylvania
9:00 AM – 11:00 AM ET
Brain fMRI Predicts Responses to Certolizumab Pegol in RA. an International, Multi-center, Randomized, Double-blind, Placebo-controlled Trial (PreCePRA) Jürgen Rech, MD – University Clinic Erlangen, Medical Department 3, Rheumatology & Immunology
9:00 AM – 11:00 AM ET
Effects of Abatacept and Tumor Necrosis Factor Inhibitor on the Normal Glycosylated Hemoglobin Level in Patients with Rheumatoid Arthritis Yusuke Miwa, MD, PhD – Division of Rheumatology, Department of Medicine, School of Medicine, Showa University
9:00 AM – 11:00 AM ET
Efficacy of Filgotinib in Patients with Rheumatoid Arthritis with Poor Prognostic Factors: Post Hoc Analysis Daniel Aletaha, MD, MS, MBA – Medical University Vienna
9:00 AM – 11:00 AM ET
Longitudinal Change in the Central Nervous System Pain Response After Treatment with Certolizumab or Placebo. a Post-hoc Analysis from the Pre-CEPRA Trial Jürgen Rech, MD – University Clinic Erlangen, Medical Department 3, Rheumatology & Immunology
9:00 AM – 11:00 AM ET
Forecasting Healthcare Utilization in Rheumatoid Arthritis: A Machine Learning Predictive Model of Emergency Department Visits and Prednisone Initiation in a Single Tertiary Academic Center Michael George, MD – University of Pennsylvania
9:00 AM – 11:00 AM ET
Prediction of Responder and Non-responder to JAK Inhibitors in Patients with Rheumatoid Arthritis: A Pilot Study with Integrative Cluster Analysis Masanari Sugawara, II, MD – Hokkaido Universitty
9:00 AM – 11:00 AM ET
The Point of No Return? Functional Disability in Patients with Rheumatoid Arthritis versus the General Population: Results from a Population-based Cohort Study Elena Myasoedova, MD, PhD – Mayo Clinic
9:00 AM – 11:00 AM ET
Body Mass Index Trajectory and Variability in Rheumatoid Arthritis Gregory J. Challener, MD – Mayo Clinic
9:00 AM – 11:00 AM ET
Comparable Long-Term Outcomes Among DAS28-ESR-based Remission Criteria and ACR/EULAR Definitions in Patients with Established Rheumatoid Arthritis Felipe Julio Ramirez Garcia, MD, PhD – Hospital Clínic
9:00 AM – 11:00 AM ET
High-Intensity Interval Training Increases Rheumatoid Arthritis Cardiorespiratory Fitness in Association with Improvements in CD4+ T Cell and Skeletal Muscle Mitochondrial Metabolism Brian J. Andonian, MD – Duke University
9:00 AM – 11:00 AM ET
Prevalence and Incidence of Infection and Venous Thromboembolism in Rheumatoid Arthritis Patients Newly Initiating Various DMARD Classes: Real-World Analysis of 2012–2016 US Medicare Data Robin Dore, MD – Robin K. Dore, MD Inc
9:00 AM – 11:00 AM ET
Rheumatoid Arthritis Affects the Ossicular Joints: A Human Otopathologic Study Melissa Castillo-Bustamante, MD – Massachusetts Eye and Ear Infirmary/Harvard University
9:00 AM – 11:00 AM ET
The Association Between the Risk of Venous Thromboembolism and Disease Activity in Patients with Rheumatoid Arthritis: A Retrospective Observational Study Masaru Yoshimura, MD – Hokkaido University
9:00 AM – 11:00 AM ET
Rheumatoid Arthritis Inpatient Mortality: An Analysis of the National Inpatient Sample Ehizogie Edigin – John H Stroger Jr. Hospital of Cook County
9:00 AM – 11:00 AM ET
Benefit and Risk Profiles of Janus Kinase Inhibitors Approved in the US for the Treatment of RA Alvin F. Wells, MD, PhD – Aurora Rheumatology and Immunotherapy Center
9:00 AM – 11:00 AM ET
Blending Hierarchical Cluster Analysis and Cluster-Specific Regressions to Predict Clinical Outcome to Tofacitinib Treatment in Patients with Rheumatoid Arthritis Robert B.M. Landewé, MD – Amsterdam University Medical Center
9:00 AM – 11:00 AM ET
Substantial Work Limitations in Patients with Rheumatoid Arthritis Despite Optimal Treat-to-Target (T2T) Drug Therapy Intervention Sara Eileen Meyer, BA – Hanover Medical School
